CX3CR1 at V249M and T280M Gene Polymorphism and Its Potential Risk for End-Stage Renal Diseases in Egyptian Patients

CX3CL1-CX3CR1 pathway may be one of the future treatment targets to delay the progression of end-stage renal diseases. This study aimed to evaluate the CX3CR gene polymorphism in Egyptian patients with ESRD and its relation to fractalkine blood level. The study included 100 patients with ESRD on dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Asmaa Fathelbab, Osman, Asmaa Osama Bakr Seddik, Elabbasy, Lamiaa M., Abdelsalam, Mostafa, Wahab, A. M., Zaki, Maysaa El Sayed, Abdel-Latif, Radwa Ahmed Rabea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093072/
https://www.ncbi.nlm.nih.gov/pubmed/33986961
http://dx.doi.org/10.1155/2021/6634365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093072/
https://www.ncbi.nlm.nih.gov/pubmed/33986961
http://dx.doi.org/10.1155/2021/6634365

Ejemplares similares